Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Clinical trial NCT00628264 · TERMINATED

Trial details

NCT number: NCT00628264
Sponsor: Action Pharma A/S
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiac Surgery Coronary Artery Bypass Grafting Valve Surgery Kidney Injury

Start date: 2008-03-01
Primary completion: 2009-06-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.